Meet Exact Sciences: The PBC company behind Cologuard
Exact Sciences joined the Phoenix Bioscience Core when it acquired a pair of Phoenix-based startups from the Translational Genomics Research Institute (TGen) and the International Genomics Consortium. The Wisconsin-based company is most well known for its at-home colorectal screening product, Cologuard.
Exact Sciences Vice President of Precision Oncology Business Operations Kevin Parker sat down with Arizona Horizon to talk about Cologuard and colorectal screenings, and also the benefits of being. apart of the Phoenix Bioscience Core.
“It’s been a great opportunity for us to join the Phoenix Bioscience Core,” Parker said. “We joined that because we think there’s a great opportunity here for growing biotech. This particular area has grown more than the average in terms of biotech jobs, and we’re proud to be part of that.”
You can watch the full interview on Arizona PBS below.
More news from the PBC
- Critical Path Institute Launches New Approach Methodologies Developer Coalition to Advance Human-Relevant Tools for Drug Development
- Christopher Finch Named New Dean at the R. Ken Coit College of Pharmacy
- ASU’s first human MRI enables breakthrough clinical studies
- Emmeline Ventures: Investing in Women’s Health, Innovation, and the Future of Venture Capital
- Arizona Microcredit Initiative Awards $7,000 in Prizes at 2nd Annual Pitch Competition for Underserved Entrepreneurs
- Connecticut mom finds healing and hope after cross-country journey to undergo rare spinal surgery in Arizona to remove dangerous malformation
- TGen appoints Nhan L. Tran, Ph.D., to faculty as distinguished professor